GenomeNet

Database: UniProt
Entry: TRIM7_MOUSE
LinkDB: TRIM7_MOUSE
Original site: TRIM7_MOUSE 
ID   TRIM7_MOUSE             Reviewed;         510 AA.
AC   Q923T7; Q5NCB6; Q99PQ5;
DT   21-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 2.
DT   27-MAR-2024, entry version 149.
DE   RecName: Full=E3 ubiquitin-protein ligase TRIM7 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000250|UniProtKB:Q9C029};
DE   AltName: Full=Glycogenin-interacting protein;
DE   AltName: Full=Tripartite motif-containing protein 7;
GN   Name=Trim7; Synonyms=Gnip;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=11331580; DOI=10.1093/emboj/20.9.2140;
RA   Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L.,
RA   Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S.,
RA   Pelicci P.G., Ballabio A.;
RT   "The tripartite motif family identifies cell compartments.";
RL   EMBO J. 20:2140-2151(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=C3H/HeJ;
RA   Skurat A.V., Dietrich A.D., Zhai L., Roach P.J.;
RT   "Identification of human skeletal muscle proteins which interact with
RT   glycogenin.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=30928727; DOI=10.1016/j.molimm.2019.01.015;
RA   Lu M., Zhu X., Yang Z., Zhang W., Sun Z., Ji Q., Chen X., Zhu J., Wang C.,
RA   Nie S.;
RT   "E3 ubiquitin ligase tripartite motif 7 positively regulates the TLR4-
RT   mediated immune response via its E3 ligase domain in macrophages.";
RL   Mol. Immunol. 109:126-133(2019).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=32126128; DOI=10.1371/journal.ppat.1008387;
RA   Yang B., Liu Y., Cui Y., Song D., Zhang G., Ma S., Liu Y., Chen M.,
RA   Chen F., Wang H., Wang J.;
RT   "RNF90 negatively regulates cellular antiviral responses by targeting MITA
RT   for degradation.";
RL   PLoS Pathog. 16:e1008387-e1008387(2020).
RN   [6]
RP   FUNCTION.
RX   PubMed=35972292; DOI=10.1128/jvi.00707-22;
RA   Sullender M.E., Pierce L.R., Annaswamy Srinivas M., Crockett S.L.,
RA   Dunlap B.F., Rodgers R., Schriefer L.A., Kennedy E.A., Stewart B.M.,
RA   Doench J.G., Baldridge M.T., Orchard R.C.;
RT   "Selective Polyprotein Processing Determines Norovirus Sensitivity to
RT   Trim7.";
RL   J. Virol. 96:e0070722-e0070722(2022).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that have both tumor-promoting
CC       and tumor-suppressing activities and functions in several biological
CC       processes including innate immunity, regulation of ferroptosis as well
CC       as cell proliferation and migration. Acts as an antiviral effector
CC       against multiple viruses by targeting specific viral proteins for
CC       ubiquitination and degradation including norovirus NTPase protein.
CC       Mechanistically, recognizes the C-terminal glutamine-containing motif
CC       generated by viral proteases that process the polyproteins and trigger
CC       their ubiquitination and subsequent degradation (PubMed:35972292).
CC       Mediates 'Lys-63'-linked polyubiquitination and stabilization of the
CC       JUN coactivator RNF187 in response to growth factor signaling via the
CC       MEK/ERK pathway, thereby regulating JUN transactivation and cellular
CC       proliferation (By similarity). Promotes the TLR4-mediated signaling
CC       activation through its E3 ligase domain leading to production of pro-
CC       inflammatory cytokines and type I interferon (PubMed:30928727). Also
CC       plays a negative role in the regulation of exogenous cytosolic DNA
CC       virus-triggered immune response. Mechanistically, enhances the 'Lys-
CC       48'-linked ubiquitination of STING1 leading to its proteasome-dependent
CC       degradation. Mediates the ubiquitination of the SIN3-HDAC chromatin
CC       remodeling complex component BRMS1. Modulates NCOA4-mediated
CC       ferritinophagy and ferroptosis in glioblastoma cells by ubiquitinating
CC       NCOA4, leading to its degradation (PubMed:32126128).
CC       {ECO:0000250|UniProtKB:Q9C029, ECO:0000269|PubMed:30928727,
CC       ECO:0000269|PubMed:32126128, ECO:0000269|PubMed:35972292}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000250|UniProtKB:Q9C029};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:Q9C029}.
CC   -!- SUBUNIT: Forms homodimers. Interacts with GNIP2. Interacts with GYG1.
CC       Interacts with RNF187 (via C-terminus). {ECO:0000250|UniProtKB:Q9C029}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9C029}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q9C029}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:Q9C029}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q923T7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q923T7-2; Sequence=VSP_012289;
CC       Name=3;
CC         IsoId=Q923T7-3; Sequence=VSP_012290, VSP_012291;
CC   -!- TISSUE SPECIFICITY: Highly expressed in antigen-presenting cells.
CC       {ECO:0000269|PubMed:30928727}.
CC   -!- DOMAIN: The B30.2 domain mediates interaction with GYG.
CC       {ECO:0000250|UniProtKB:Q9C029}.
CC   -!- DOMAIN: The coiled-coil region mediates homodimerization and
CC       heterodimerization. {ECO:0000250|UniProtKB:Q9C029}.
CC   -!- PTM: Phosphorylated at Ser-106 by RPS6KA5/MSK1, which stimulates the
CC       ubiquitin ligase activity. {ECO:0000250|UniProtKB:Q9C029}.
CC   -!- PTM: Auto-ubiquitinates via 'Lys-63'-linked polyubiquitination.
CC       {ECO:0000250|UniProtKB:Q9C029}.
CC   -!- DISRUPTION PHENOTYPE: Deletion mutant protects mice from DNA virus
CC       infection. {ECO:0000269|PubMed:32126128}.
CC   -!- SIMILARITY: Belongs to the TRIM/RBCC family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF220033; AAG53487.1; -; mRNA.
DR   EMBL; AF396656; AAK85382.1; -; mRNA.
DR   EMBL; AL645849; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS48779.1; -. [Q923T7-2]
DR   CCDS; CCDS83797.1; -. [Q923T7-1]
DR   RefSeq; NP_444396.2; NM_053166.2. [Q923T7-2]
DR   RefSeq; XP_006534638.1; XM_006534575.3. [Q923T7-2]
DR   AlphaFoldDB; Q923T7; -.
DR   SMR; Q923T7; -.
DR   BioGRID; 220444; 2.
DR   STRING; 10090.ENSMUSP00000039011; -.
DR   GlyGen; Q923T7; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q923T7; -.
DR   PhosphoSitePlus; Q923T7; -.
DR   PaxDb; 10090-ENSMUSP00000104836; -.
DR   ProteomicsDB; 298127; -. [Q923T7-1]
DR   ProteomicsDB; 298128; -. [Q923T7-2]
DR   ProteomicsDB; 298129; -. [Q923T7-3]
DR   Antibodypedia; 29710; 174 antibodies from 27 providers.
DR   DNASU; 94089; -.
DR   Ensembl; ENSMUST00000109213.9; ENSMUSP00000104836.3; ENSMUSG00000040350.17. [Q923T7-2]
DR   GeneID; 94089; -.
DR   KEGG; mmu:94089; -.
DR   UCSC; uc007ipd.2; mouse. [Q923T7-1]
DR   AGR; MGI:2137353; -.
DR   CTD; 81786; -.
DR   MGI; MGI:2137353; Trim7.
DR   VEuPathDB; HostDB:ENSMUSG00000040350; -.
DR   eggNOG; KOG2177; Eukaryota.
DR   GeneTree; ENSGT01030000234669; -.
DR   HOGENOM; CLU_013137_0_0_1; -.
DR   InParanoid; Q923T7; -.
DR   OMA; DMKMHIC; -.
DR   PhylomeDB; Q923T7; -.
DR   TreeFam; TF317532; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 94089; 3 hits in 62 CRISPR screens.
DR   ChiTaRS; Trim7; mouse.
DR   PRO; PR:Q923T7; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q923T7; Protein.
DR   Bgee; ENSMUSG00000040350; Expressed in right kidney and 125 other cell types or tissues.
DR   ExpressionAtlas; Q923T7; baseline and differential.
DR   Genevisible; Q923T7; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISO:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0140374; P:antiviral innate immune response; ISO:MGI.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   CDD; cd19762; Bbox2_TRIM7-like; 1.
DR   CDD; cd16594; RING-HC_TRIM7-like_C-IV; 1.
DR   CDD; cd13740; SPRY_PRY_TRIM7; 1.
DR   Gene3D; 2.60.120.920; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR043136; B30.2/SPRY_sf.
DR   InterPro; IPR003879; Butyrophylin_SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR006574; PRY.
DR   InterPro; IPR003877; SPRY_dom.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR020457; Znf_B-box_chordata.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR24103; E3 UBIQUITIN-PROTEIN LIGASE TRIM; 1.
DR   PANTHER; PTHR24103:SF689; E3 UBIQUITIN-PROTEIN LIGASE TRIM7; 1.
DR   Pfam; PF13765; PRY; 1.
DR   Pfam; PF00622; SPRY; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   Pfam; PF15227; zf-C3HC4_4; 1.
DR   PRINTS; PR01406; BBOXZNFINGER.
DR   PRINTS; PR01407; BUTYPHLNCDUF.
DR   SMART; SM00336; BBOX; 1.
DR   SMART; SM00589; PRY; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00449; SPRY; 1.
DR   SUPFAM; SSF57845; B-box zinc-binding domain; 1.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50188; B302_SPRY; 1.
DR   PROSITE; PS50119; ZF_BBOX; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Antiviral defense; Coiled coil; Cytoplasm;
KW   Golgi apparatus; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transferase; Ubl conjugation; Ubl conjugation pathway;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..510
FT                   /note="E3 ubiquitin-protein ligase TRIM7"
FT                   /id="PRO_0000056205"
FT   DOMAIN          323..510
FT                   /note="B30.2/SPRY"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00548"
FT   ZN_FING         29..81
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         124..165
FT                   /note="B box-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   COILED          165..275
FT                   /evidence="ECO:0000255"
FT   BINDING         129
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         132
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         151
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         157
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   MOD_RES         106
FT                   /note="Phosphoserine; by RPS6KA5"
FT                   /evidence="ECO:0000250|UniProtKB:Q9C029"
FT   VAR_SEQ         1..207
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_012289"
FT   VAR_SEQ         206..243
FT                   /note="KQMAAEKEKVGAEFQALRAFLVEQEGRLLSRLEVLSRE -> VSPSVRSIGL
FT                   WMTKAERERERERERERERERERIWLKQ (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11331580"
FT                   /id="VSP_012290"
FT   VAR_SEQ         244..510
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11331580"
FT                   /id="VSP_012291"
SQ   SEQUENCE   510 AA;  57021 MW;  01335C644BFFA4E3 CRC64;
     MATVGPRTGP NAGAEALALA AELQGEATCS ICLEFFREPV SVECGHSFCR ACIMRCWERP
     GAGTGTATRT LPCPLPCPQC REPARPSQLR PNRQLAAVVS LLRRFSLPPT APGERGTPAV
     PARAAAARCS QHGEQLKLYC QDDGRAICVV CDRAREHRSH AVLPLEEAVQ EAKELLDSRL
     RALKKVLEDY EAFRSTEERE SKELLKQMAA EKEKVGAEFQ ALRAFLVEQE GRLLSRLEVL
     SREVTQKQNE NLAQLEGEIT QLSKLSGQIQ ETAQKPDLDF LQEFKSTLSK CSSVPSSKPT
     TVSSEMKNKV WNVSLKSFVL KGLLKKFKED LQGELEKEEK VELTLDPDTA NPRLILSLDL
     KSVRLGQRAQ DLPNHPRRFD TNTRVLASCG FSSGRHHWEV EVGSKDGWAF GVARESVRRK
     GLTPFTPEEG VWAMQLNNGQ YWAVTSPERT QLNCGHLSRV RVALDLEVGA VSFYAVEDMR
     HLYTFRVNFQ ERVFPLFSVC STGTYLRIWP
//
DBGET integrated database retrieval system